# LapSpace Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lapspace-medical

- Industry: Medical Devices & Equipment
- Headquarters: Israel
- Website: www.lapspacemedical.com
- Total disclosed funding: $1M
- Latest round: Seed (Nov 12, 2013)
- Investors on record: 2

## About

LapSpace Medical Ltd. is a medical device company focused on the development and commercialization of innovative surgical solutions designed to enhance patient outcomes and streamline surgical procedures.LapSpace Medical Ltd. was founded in 2011 in Israel and specializes in advanced surgical technologies. The company has undergone no major pivots or changes in business strategy since its inception. It was founded by a team of experts in the medical device industry. In November 2013, LapSpace Medical Ltd. raised USD 1 mn in Seed funding from Trendlines Group and the Office of the Chief Scientist of Israel, marking the total amount raised to USD 1 mn.LapSpace Medical Ltd. develops and produces advanced surgical solutions that enhance surgical procedures and patient care. Their product offerings include innovative devices designed to improve the efficiency and effectiveness of surgeries, catering primarily to hospitals and healthcare providers. The company focuses on integrating cutting-edge technology to address specific medical needs, ensuring high standards of safety and performance in surgical applications.The revenue model of LapSpace Medical Ltd. is based on direct sales to healthcare institutions and partnerships with medical distributors. The company engages in transactions through bulk sales to hospitals, as well as direct sales through its proprietary channels. Established pricing tiers cater to both institutional clients and individual surgical practitioners, ensuring accessibility to their innovative solutions.LapSpace Medical Ltd. plans to expand its product line with new surgical technologies aimed at improving surgical outcomes, with potential launches scheduled for late 2024. The company is also targeting expansion into European and North American markets by 2025, aiming to establish a broader presence in regions with increasing demand for surgical innovations. The recent Seed funding of USD 1 mn will be utilized to support product development and market entry initiatives, enabling the company to enhance its operational capacity and reach new customers.

## Funding rounds

- Seed, Nov 12, 2013, $1M — Trendlines Group, The Office of the Chief Scientist

## Investors

- Trendlines Group (https://capitalatlas.ai/funds/trendlines-group) — Seed
- The Office of the Chief Scientist — Seed